These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 24512984)
1. Mesenchymal stem cells and cancer: friends or enemies? Hong IS; Lee HY; Kang KS Mutat Res; 2014 Oct; 768():98-106. PubMed ID: 24512984 [TBL] [Abstract][Full Text] [Related]
3. Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6. Lin JT; Wang JY; Chen MK; Chen HC; Chang TH; Su BW; Chang PJ Exp Cell Res; 2013 Aug; 319(14):2216-29. PubMed ID: 23751564 [TBL] [Abstract][Full Text] [Related]
4. Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 delivery. Zhang X; Zhang L; Xu W; Qian H; Ye S; Zhu W; Cao H; Yan Y; Li W; Wang M; Wang W; Zhang R Curr Cancer Drug Targets; 2013 Jan; 13(1):92-102. PubMed ID: 23170786 [TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles derived from renal cancer stem cells induce a pro-tumorigenic phenotype in mesenchymal stromal cells. Lindoso RS; Collino F; Camussi G Oncotarget; 2015 Apr; 6(10):7959-69. PubMed ID: 25797265 [TBL] [Abstract][Full Text] [Related]
6. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells. Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. Galiè M; Konstantinidou G; Peroni D; Scambi I; Marchini C; Lisi V; Krampera M; Magnani P; Merigo F; Montani M; Boschi F; Marzola P; Orrù R; Farace P; Sbarbati A; Amici A Oncogene; 2008 Apr; 27(18):2542-51. PubMed ID: 17998939 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell-tumor cell cooperation in breast cancer vasculogenesis. Comşa S; Ciuculescu F; Raica M Mol Med Rep; 2012 May; 5(5):1175-80. PubMed ID: 22367291 [TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells in lung cancer tumor microenvironment: their biological properties, influence on tumor growth and therapeutic implications. Liu R; Wei S; Chen J; Xu S Cancer Lett; 2014 Oct; 353(2):145-52. PubMed ID: 25128070 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Roorda BD; ter Elst A; Kamps WA; de Bont ES Crit Rev Oncol Hematol; 2009 Mar; 69(3):187-98. PubMed ID: 18675551 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells. Norozi F; Ahmadzadeh A; Shahrabi S; Vosoughi T; Saki N Tumour Biol; 2016 Sep; 37(9):11679-11689. PubMed ID: 27440203 [TBL] [Abstract][Full Text] [Related]
12. Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy. Keung EZ; Nelson PJ; Conrad C Stem Cells; 2013 Feb; 31(2):227-35. PubMed ID: 23132810 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer. Kikuchi H; Yagi H; Hasegawa H; Ishii Y; Okabayashi K; Tsuruta M; Hoshino G; Takayanagi A; Kitagawa Y J Surg Res; 2014 Jul; 190(1):134-43. PubMed ID: 24679698 [TBL] [Abstract][Full Text] [Related]
14. The Microenvironment of Lung Cancer and Therapeutic Implications. Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800 [TBL] [Abstract][Full Text] [Related]
15. Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets. Shi Y; Du L; Lin L; Wang Y Nat Rev Drug Discov; 2017 Jan; 16(1):35-52. PubMed ID: 27811929 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells show little tropism for the resting and differentiated cancer stem cell-like glioma cells. Liu Z; Jiang Z; Huang J; Huang S; Li Y; Sheng F; Yu S; Yu S; Liu X Int J Oncol; 2014 Apr; 44(4):1223-32. PubMed ID: 24481670 [TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells and mesenchymal stem cells in the hypoxic tumor niche: two different targets for one only drug. Bonafè F; Guarnieri C; Muscari C Med Hypotheses; 2015 Mar; 84(3):227-30. PubMed ID: 25620576 [TBL] [Abstract][Full Text] [Related]
18. In vitro expanded bone marrow-derived murine (C57Bl/KaLwRij) mesenchymal stem cells can acquire CD34 expression and induce sarcoma formation in vivo. Xu S; De Becker A; De Raeve H; Van Camp B; Vanderkerken K; Van Riet I Biochem Biophys Res Commun; 2012 Aug; 424(3):391-7. PubMed ID: 22771324 [TBL] [Abstract][Full Text] [Related]
19. Cancer stemness and metastatic potential of the novel tumor cell line K3: an inner mutated cell of bone marrow-derived mesenchymal stem cells. Qian H; Ding X; Zhang J; Mao F; Sun Z; Jia H; Yin L; Wang M; Zhang X; Zhang B; Yan Y; Zhu W; Xu W Oncotarget; 2017 Jun; 8(24):39522-39533. PubMed ID: 28465472 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell signaling in cancer progression. Torsvik A; Bjerkvig R Cancer Treat Rev; 2013 Apr; 39(2):180-8. PubMed ID: 22494966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]